Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma

被引：0
|
作者：
Shree, Tanaya [1 ]
Shankar, Vishnu [1 ]
Czerwinski, Debra K. [2 ]
Rodriguez, Gladys [1 ]
Beygi, Sara [3 ,4 ]
Schroers-Martin, Joseph G. [5 ,6 ]
Advani, Ranjana [7 ]
Maeda, Lauren S. [2 ,8 ]
Gupta, Neel K. [2 ,8 ]
Khodadoust, Michael S. [1 ,9 ]
Kurtz, David M. [1 ]
Corbelli, Karen S. [10 ]
Gabriel, Etelka [1 ]
Kanegai, Alyssa M. [1 ]
Alizadeh, Ash A. [11 ,12 ]
Levy, Ronald [1 ]
机构：
[1] Stanford Univ, Dept Med, Div Oncol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Div Oncol, Dept Med, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA
[5] Stanford Univ, Div Hematol, Dept Med, Stanford, CA USA
[6] Stanford Univ, Div Oncol, Dept Med, Stanford, CA USA
[7] Stanford Canc Inst, Lymphoma, Dept Med, Div Oncol, Stanford, CA USA
[8] Stanford Univ, Med Ctr, Div Hematol, Dept Med, Stanford, CA 94305 USA
[9] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA
[10] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[11] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA
[12] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153901
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2064
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 vaccine in a cohort of patients with multiple sclerosis
    Correa-Diaz, E. P.
    Barrera Madera, R.
    Torres Herran, G.
    Jacome Sanchez, C.
    Gualotuna Pachacama, W.
    Llerena Pallango, A.
    Piedra Andrade, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 838 - 838
  • [2] Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
    Houot, Roch
    Levy, Ronald
    Cartron, Guillaume
    Armand, Philippe
    EUROPEAN JOURNAL OF CANCER, 2020, 136 : 4 - 6
  • [3] Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma
    Dillman, RO
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3545 - 3557
  • [4] Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery
    Feige, Julia
    Berek, Klaus
    Seiberl, Michael
    Hilpold, Patrick
    Hitzl, Wolfgang
    Di Pauli, Franziska
    Hegen, Harald
    Deisenhammer, Florian
    Trinka, Eugen
    Harrer, Andrea
    Wipfler, Peter
    Moser, Tobias
    NEUROLOGY INTERNATIONAL, 2022, 14 (04): : 943 - 951
  • [5] Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?
    Jeantin, Lina
    Abdi, Basma
    Soulie, Cathia
    Sterlin, Delphine
    Maillart, Elisabeth
    Beigneux, Ysoline
    Hippolyte, Amandine
    Belin, Lisa
    Marcelin, Anne-Genevieve
    Pourcher, Valerie
    Louapre, Celine
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (01): : 19 - 28
  • [6] Anti-CD20 monoclonal antibody as a new treatment modality for B-cell lymphoma
    Hotta, T
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2002, 35 (04) : 275 - 279
  • [7] Interaction of anti-CD20 antibodies and inhibitors of the B-cell receptor pathway in diffuse large B-cell lymphoma
    Peter, N.
    Zoellner, A. K.
    Zimmermann, Y.
    Hutter, G.
    Hiddemann, W.
    Dreyling, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 72 - 72
  • [8] Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases
    Martinez-Chinchilla, Carlos
    Vazquez-Montero, Lucia
    Palazon-Carrion, Natalia
    Fernandez-Roman, Isabel M.
    Lopez-Barba, Jose
    De la Cruz-Merino, Luis
    Rodriguez-Bano, Jesus
    Palacios-Baena, Zaira R.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies
    Gressens, Simon B.
    Wiedemann, Aurelie
    Dechenaud, Marie
    Dupuis, Jehan
    Gallien, Sebastien
    Melica, Giovanna
    Haioun, Corinne
    Lemonnier, Francois
    Levy, Yves
    VACCINE, 2023, 41 (09) : 1550 - 1553
  • [10] Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis
    Schwarz, Tatjana
    Otto, Carolin
    Jones, Terry C.
    Pache, Florence
    Schindler, Patrick
    Niederschweiberer, Moritz
    Schmidt, Felix A.
    Drosten, Christian
    Corman, Victor M.
    Ruprecht, Klemens
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1041 - 1050
12345